- Imaging: New Era of Neuroimaging for Alzheimer’s Disease
-
Kim JS
- KMID: 2505753
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):161-162.
- doi: 10.1007/s13139-020-00657-4
-
- CITED
-
- Close
- SHARE
-
- Close
- Message from the Editor-in-Chief
-
Lee DS
- KMID: 2505752
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):157-160.
- doi: 10.1007/s13139-020-00653-8
-
- CITED
-
- Close
- SHARE
-
- Close
- Physiological Uptake of Radioactive Iodine Around an ArtificialEyeball Observed with Single-Photon Emission ComputedTomography/Computed Tomography After RadioactiveIodine Treatment
-
Lee JY, Song HS, Kang M
- KMID: 2505760
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):204-206.
- doi: 10.1007/s13139-020-00651-w
Radioactive iodine treatment is useful for ablating remnant thyroid tissue and metastasis ofwell-differentiated thyroid cancer withlong-lasting effects. A scintigraphy after radioactive iodine treatment is a major imaging modality for detecting... -
- CITED
-
- Close
- SHARE
-
- Close
- 68Ga DOTA-TOC Uptake in Non-ossifying Fibroma: a Case Report
-
Khalaf A, Hirmas N, Anwer F, Al-Ibraheem A
- KMID: 2505759
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):199-203.
- doi: 10.1007/s13139-020-00650-x
Non-ossifying fibroma (NOF) is a common benign bone tumor with a high probability of occurrence in children and adolescents.It is commonly seen in the metaphysis of long bones, eccentrically located,... -
- CITED
-
- Close
- SHARE
-
- Close
- KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic
-
Bang JI, Lee HY, Cho YS, Choi H, Chong A, Eo JS, Kim JY, Kim TS, Kwon HW, Lee EJ, Lee ES, Park HL, Park SB, Shim Hk, Song BI, Yoo ID, Lee KJ, Lee HJ, Han SH, Lee JS, Park JM, Kim SH
- KMID: 2505754
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):163-167.
- doi: 10.1007/s13139-020-00660-9
The dramatic spread of Coronavirus Disease 2019 (COVID-19) has profound impacts on every continent and life. Due to humanto-human transmission of COVID-19, nuclear medicine staffs also cannot escape the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site
-
Yoo SW, Chowdhury MSA, Jeon S, Kang SR, Lee C, Jabin Z, Kim J, Cho SG, Song HC, Bom HS, Min JJ, Kwon SY
- KMID: 2505758
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):192-198.
- doi: 10.1007/s13139-020-00649-4
Purpose We investigated the clinical role of F-18 fluorodeoxyglucose (FDG) positron emission tomography-computed tomography(PET-CT) in the identification of the primary site and the selection of the optimal biopsy site in... -
- CITED
-
- Close
- SHARE
-
- Close
- Association Between Colonic18F-FDG Uptake and Glycemic Control in Patients with Diabetes Mellitus
-
Chang HS, Kim SJ, Kim YH
- KMID: 2505755
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):168-174.
- doi: 10.1007/s13139-020-00647-6
Purpose Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) is a useful imagingmodalitythat visualizes glucose utilization. Diffuse colonic FDG uptake is frequently observed in patients being treated fordiabetes mellitus (DM),... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship of EGFR Mutation to Glucose Metabolic Activityand Asphericity of Metabolic Tumor Volumein Lung Adenocarcinoma
-
Whi W, Ha S, Bae S, Choi H, Paeng JC, Cheon GJ, Kang KW, Lee DS
- KMID: 2505756
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):175-182.
- doi: 10.1007/s13139-020-00646-7
Purpose EGFR-mutation (EGFR-mt) is a major oncogenic driver mutation in lung adenocarcinoma (ADC) and is more oftenobserved in Asian population. In lung ADC, some radiomics parameters of FDG PET have... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Suspected Malignancy or Infectionin Immunocompromised Patients After Solid Organ Transplantationby [18F]FDG PET/CT and [18F]FDG PET/MRI
-
Guberina N, Gäckler A, Grueneisen J, Wetter A, Witzke O, Herrmann K, Rischpler C, Fendler W, Umutlu L, Sawicki LM, Forsting M, Rohn H
- KMID: 2505757
- Nucl Med Mol Imaging.
- 2020 Aug;54(4):183-191.
- doi: 10.1007/s13139-020-00648-5
Purpose To study the value of 2-deoxy-2-[18F]fluoro-D-glucose([18F]FDG) positron emission tomography/computed tomography(PET/CT) and [18F]FDG positron emission tomography/magnetic resonance imaging (PET/MRI) in assessing immunocompromisedpatients with suspected malignancy or infection. Methods [18F]FDG-PET/CT and [18F]FDG-PET/MRI... -
- CITED
-
- Close
- SHARE
-
- Close
